Kazia Therapeutics Annual Reports 2023

12 OUR CORPORATE RESPONSIBILITY ENVIRONMENT Climate Change Kazia is mindful of its impact on the environment and strives to reduce its carbon footprint. The Kazia business model is based on outsourcing, and we are working with major partners who are focused on reducing climate change and enhancing climate protection. Our major partner Evotec, who is running our EVT-801 trial, is a signatory to one of the most ambitious actions related to climate mitigation, the Science Based Targets initiative (SBTi). This implies to set carbon reduction targets aligned with the goals of the Paris Agreement: to limit global warming to well below 2°C above pre-industrial levels and pursue efforts to limit warming to 1.5°C and is determined to become net carbon neutral by 2050. Evotec is implementing an innovative, web-based platform to collect environmental, social and governance indicators. This will allow them to identify sustainability-related risks at an early stage and derive appropriate measures. In this way, the large number of projects that Evotec have already implemented in the area of environmental protection and resource conservation can also be systematically mapped in the future. This includes, among other things, the procurement of green electricity and the conversion of office paper to 100 % recycled material. Sustainability Kazia head office is located in one of the most sustainable carbon neutral commercial precincts in the world. The serviced office is located in a building with a five‑star NABERS energy rating. ENVIRONMENT, SOCIETY & GOVERNANCE Countries we treat compassionate patients in: Australia, USA, Israel, Spain, Switzerland, England and Ireland SOCIETY Community Contribution Our compassionate program has treated over 40 patients in 7 countries since its inception in 2018. 40 PATIENTS IN 7 COUNTRIES SINCE 2018

RkJQdWJsaXNoZXIy MjE2NDg3